Harriet de Wit
Direktor/Vorstandsmitglied bei PHARMALA BIOTECH HOLDINGS INC.
Vermögen: 15 800 $ am 30.04.2024
Aktive Positionen von Harriet de Wit
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Direktor/Vorstandsmitglied | 21.03.2021 | - |
| The University of Chicago | Corporate Officer/Principal | - | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Harriet de Wit
Ausbildung von Harriet de Wit
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Statistik
International
| Kanada | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Harriet de Wit
- Erfahrung
